How AI Transforms the Facets of Neurotech?

StartUp City | Wednesday, April 14, 2021

How AI Transforms the Facets of Neurotech?One area of Neurotech that many people are familiar with is the brain-computer interface (BCI). Brain-computer interfaces (BCIs) receive brain signals, interpret them, and convert them into commands that are sent to output devices that carry out the appropriate behavior.

FREMONT, CA: Neurotechnologies are developed on the principles of the human nervous system and modeled on the human brain. Neurotech can assist researchers in understanding brain function and dysfunction and can also help doctors treat neurological disorders. Some neurotech applications are designed to enhance cognitive performance, improving sleep, and improve brain health. Advances in AI have revolutionized Neurotech for quite some time now. Neurotech has enormous space for growth both in terms of technology and as an industry.

Brain Computer Interface

Top 10 BioTech StartupsMany people are already familiar with neurotech's brain-computer interface (BCI). One area of NeuroTech that many people are familiar with is the brain-computer interface (BCI). Brain-computer interfaces (BCIs) receive brain signals, interpret them, and convert them into commands that are sent to output devices that carry out the appropriate behavior. People with neuromuscular disabilities such as amyotrophic lateral sclerosis, cerebral palsy, stroke, or spinal cord injury could benefit from BCI. Humans will be able to have USB ports inserted in their brains as technology progresses, allowing them to upload data. By 2024, the global BCI market is estimated to be worth $1.8 billion.

Neuromodulation

Neuromodulation is a form of brain stimulation that involves stimulating particular areas of the brain. Neuromodulatory stimuli come in a variety of forms, each with its own set of characteristics and applications. In the United States, more than 150,000 individuals have surgical brain implants, mostly to treat Parkinson's disease. For the treatment of chronic diseases, neuromodulation therapies are a viable alternative to pharmaceuticals. Compared to pharmaceuticals, these drugs are more targeted, less costly, and have fewer side effects. One important application of this technology is a treatment for unbearable pain that requires stimulating the spinal and peripheral nervous system in separate parts of the brain. The global neuromodulation device industry is anticipated to grow to $13.3 billion by 2022.

See Also: Top Emerging Neurology Device Providers

Weekly Brief